PBS price changes
October 26, 2012
THE Government will alter the
cost of 11 medicines on the
Pharmaceutical Benefits Scheme, in
line with recommendations made
by the Pharmaceutucal Benefits
Pricing Authority.
Nine of the medicines will
increase in cost, including: Uro-carb
(bethanechol), Cal-Sup (calcium),
Dantrium (dantrolene), Deptran
(doxepin), Natrilix SR (indapamide),
Zeffix® 3TC (lamivudine), Lincocin
(lincomycin), Synarel (nafarelin),
and Macrodantin (nitrofurantoin).
The remaining two drugs:
Cetrotide (cetrorelix) and
Orgalutran (ganirelix) will have their
prices reduced.
The changes are due to take
effect from 1 December 2012,
subject to final arrangements being
met by the suppliers of the
medicines.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Oct 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Oct 12